Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer

Head and Neck

Volumn 21, Issue 3, 1999, Pages 223-228

  Sanguineti, Giuseppe ^a   Corvo, Renzo ^a   Benasso, Marco ^a   Margarino, Giovanni ^a   Sormani, MariaPia ^a   Roncallo, Federico ^a   Mereu, Paola ^a   Bacigalupo, Almalina ^a   Vitale, Vito ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Chemoradiotherapy; Head and neck cancer; Neck metastasis; Planned neck dissection; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MALE; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; NECK METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0032956870     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0347(199905)21:3<223::aid-hed7>3.3.co;2-r     Document Type: Article

References (27)

1. Million RR, Cassisi NJ, editors. Management of head and neck cancer: a multidisciplinary approach, 2nd ed., Philadelphia: JB Lippincott; 1994. p 75-141.
2. Fletcher GH. Elective irradiation of subclinical disease in cancers of the head and neck. Cancer 1972;29:1450-1454.
3. Barkley HT, Fletcher GH, Jesse RH, et al. Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx and hypopharynx. Am J Surg 1972;124:462-467.
4. Bataini JP, Bernier J, Jaullerry C, et al. Impact of cervical disease and its definitive radiotherapeutic management on survival: experience in 2013 patients with squamous cell carcinomas of the oropharynx and pharyngolarynx. Laryngoscope 1990;100:716-723.
5. Mendenhall WM, Million RR, Bova FJ. Analysis of time-dose factors in clinically positive neck nodes treated with irradiation alone in squamous cell carcinoma of the head and neck. Int J Rad Oncol Biol Phys 10:639-643, 1984
6. Mendehall WM, Million RR, Cassisi NJ. Squamous cell carcinoma of the head and neck treated with radiation therapy: the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 1986;12: 733-740.
7. Bernier J, Bataini JP. Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy. Analysis of neck disease response in 1646 cases. Radiother Oncol 1986;6:87-103.
8. Peters LJ, Weber RS, Morrison WH, et al. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 1996;18:552-555.
9. Lavertu P, Adelstein DJ, Saxton JP, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997;19:559-566.
10. Koch WM, Lee DJ, Eisele DW, et al. Chemoradiotherapy for organ preservation in oral and pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1995;121:974-980.
11. Armstrong J, Pfister D, Strong E, et al. The management of clinically positive neck as part of a larynx preservation approach. Int J Radiat Oncol Biol Phys 1993;26:759-765.
12. Norris CM, Busse PM, Clark JR. Evolving role of surgery after induction chemotherapy and primary site radiation in head and neck cancer. Semin Surg Oncol 1993;9:3-13.
13. Slotman GJ, Doolittle CH, Glicksman AS. Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Cancer 1992;69:2736-2743.
14. Wolf GT, Fisher SG. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 1992;102:934-939.
15. Merlano M, Vitale V, Rosso R, et al. Treatment of advanced SCC of the HN with alternating chemotherapy and radiotherapy. N Engl J Med 1992;327:1115-1121.
16. Ang KK, Kaander JHAM, Peters LJ. Radiotherapy for head and neck cancers. Philadelphia: Lea & Febiger; 1994. p 25-42.
17. Bataini JP, Bernier J, Jaulerry P, Brunin F, Pontvert D, Lave C. Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancers managed by definitive radiotherapy. Int J Radiat Oncol Biol Phys 1987;13: 817-824.
18. Ensley JF, Maciorowski Z, Hassan M, et al. Cellular DNA content parameters in untreated and recurrent squamous cell cancers of the head and neck. Cytometry 1989;10: 334-338.
19. Wolf GT, Fisher SG, Truelson JM, et al. DNA content and regional metastases in patients with advanced laryngeal squamous carcinoma. Laryngoscope 1994;104:479-482.
20. Corvò R, Giaretti W, Sanguineti G, et al. Chemoradiotherapy as an alternative to radiotherapy alone in fast proliferating head and neck squamous cell carcinomas. Clin Cancer Res 1997;3:1993-1997.
21. Hockel M, Schlenger K, Mitze M, et al. Hypoxia and radiation response in human tumors. Sem Radiat Oncol, 1996;6:3-9.
22. Roncallo F, Turtulici I, Bartolini A, et al. Tomografia computerizzata e risonanza magnetica nella patologia del distretto testa e collo. Riv Neuroradiol 1996;9:471-491.
23. Newman J, Dagum P, Pinto H, et al. Pathologic findings in clinically postive neck disease after chemmoradiotherapy for organ preservation in advanced head and neck cancer, 4th International Conference on Head and Neck Cancer, Toronto, July 28-August 1, 1996:102.
24. Lavertu P, Adelstein AJ, Saxton JP, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiation therapy with radiation alone in resectable stage III and IV squamous cell head and neck cancer, 4th International Conference on Head and Neck Cancer, Toronto, July 28-August 1, 1996:102.
25. Taylor SG, Murthy AK, Vannetzel JM, et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Cl Oncol 1994; 12:385-395.
26. Anzay Y, Carrol WR, Quint DT, et al. Recurrence of head and neck cancer after surgery and irradiation: prospective comparison of 2-deoxy-2-[f-18] Fluoro-D-glucose PET and MR imaging diagnosis. Radiology 1996;200:135-141.
27. Greven KM, Williams DW, Keyes JW, et al. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer. Int J Rad Oncol Biol Phys 1994;29:841-845.